Oseltamavir: Difference between revisions
| Line 9: | Line 9: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
5 day course | |||
*1-8 months: 6 mg/kg/day PO divided BID | |||
*9-23 months: 7 mg/kg/day PO divided BID | |||
*2-12 years: | |||
==Special Populations== | ==Special Populations== | ||
Revision as of 19:31, 19 June 2015
General
- Type:
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Influenza
75mg PO BID x5d
Pediatric Dosing
5 day course
- 1-8 months: 6 mg/kg/day PO divided BID
- 9-23 months: 7 mg/kg/day PO divided BID
- 2-12 years:
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: